Cargando…
Increased risk of central line-associated bloodstream infection in COVID-19 patients associated with dexamethasone but not with interleukin antagonists
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171741/ https://www.ncbi.nlm.nih.gov/pubmed/35670819 http://dx.doi.org/10.1007/s00134-022-06750-w |
| _version_ | 1784721733598576640 |
|---|---|
| author | Meynaar, Iwan A. van Rijn, Simone Ottens, Thomas H. van Burgel, Nathalie D. van Nieuwkoop, Cees |
| author_facet | Meynaar, Iwan A. van Rijn, Simone Ottens, Thomas H. van Burgel, Nathalie D. van Nieuwkoop, Cees |
| author_sort | Meynaar, Iwan A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9171741 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91717412022-06-08 Increased risk of central line-associated bloodstream infection in COVID-19 patients associated with dexamethasone but not with interleukin antagonists Meynaar, Iwan A. van Rijn, Simone Ottens, Thomas H. van Burgel, Nathalie D. van Nieuwkoop, Cees Intensive Care Med Letter Springer Berlin Heidelberg 2022-06-07 2022 /pmc/articles/PMC9171741/ /pubmed/35670819 http://dx.doi.org/10.1007/s00134-022-06750-w Text en © Springer-Verlag GmbH Germany, part of Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letter Meynaar, Iwan A. van Rijn, Simone Ottens, Thomas H. van Burgel, Nathalie D. van Nieuwkoop, Cees Increased risk of central line-associated bloodstream infection in COVID-19 patients associated with dexamethasone but not with interleukin antagonists |
| title | Increased risk of central line-associated bloodstream infection in COVID-19 patients associated with dexamethasone but not with interleukin antagonists |
| title_full | Increased risk of central line-associated bloodstream infection in COVID-19 patients associated with dexamethasone but not with interleukin antagonists |
| title_fullStr | Increased risk of central line-associated bloodstream infection in COVID-19 patients associated with dexamethasone but not with interleukin antagonists |
| title_full_unstemmed | Increased risk of central line-associated bloodstream infection in COVID-19 patients associated with dexamethasone but not with interleukin antagonists |
| title_short | Increased risk of central line-associated bloodstream infection in COVID-19 patients associated with dexamethasone but not with interleukin antagonists |
| title_sort | increased risk of central line-associated bloodstream infection in covid-19 patients associated with dexamethasone but not with interleukin antagonists |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171741/ https://www.ncbi.nlm.nih.gov/pubmed/35670819 http://dx.doi.org/10.1007/s00134-022-06750-w |
| work_keys_str_mv | AT meynaariwana increasedriskofcentrallineassociatedbloodstreaminfectionincovid19patientsassociatedwithdexamethasonebutnotwithinterleukinantagonists AT vanrijnsimone increasedriskofcentrallineassociatedbloodstreaminfectionincovid19patientsassociatedwithdexamethasonebutnotwithinterleukinantagonists AT ottensthomash increasedriskofcentrallineassociatedbloodstreaminfectionincovid19patientsassociatedwithdexamethasonebutnotwithinterleukinantagonists AT vanburgelnathalied increasedriskofcentrallineassociatedbloodstreaminfectionincovid19patientsassociatedwithdexamethasonebutnotwithinterleukinantagonists AT vannieuwkoopcees increasedriskofcentrallineassociatedbloodstreaminfectionincovid19patientsassociatedwithdexamethasonebutnotwithinterleukinantagonists |